Quality of life in patients with irritable bowel syndrome

Journal of Clinical Gastroenterology

Volumn 45, Issue SUPPL. 2, 2011, Pages

  Mönnikes, Hubert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

constipation; diarrhea; irritable bowel syndrome; quality of life; review

Indexed keywords

ALOSETRON; COLOFAC MR; MEBEVERINE; UNCLASSIFIED DRUG;

CONSTIPATION; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; FUNCTIONAL ASSESSMENT; GASTROESOPHAGEAL REFLUX; HEALTH STATUS; HUMAN; IRRITABLE COLON; KIDNEY FAILURE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE;

AGED; CARBOLINES; CONSTIPATION; DIARRHEA; FEMALE; GASTROINTESTINAL AGENTS; HEALTH STATUS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; PHENETHYLAMINES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79958811036     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31821fbf44     Document Type: Review

References (22)

1. World Health Organization. Constitution of the World Health Organization. Handbook of Basic Documents. 5th ed. Geneva: WHO; 1948:3-20.
2. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med. 1995;122:107-112.
3. Hahn BA, Kirchdoerfer LJ, Fullerton S, et al. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther. 1997;11:547-552. (Pubitemid 27286957)
4. Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion. 1999;60:77-81. (Pubitemid 29042096)
5. Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654-660.
6. O'Keefe EA, Talley NJ, Zinsmeister AR, et al. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol Med Sci. 1995;50A:M184-M189.
7. Wong RK, Drossman DA. Quality of life measures in irritable bowel syndrome. Expert Rev Gastroenterol. 2010;4:277-284.
8. Pace F, Molteni P, Bollani S, et al. Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol. 2003;38:1031-1038. (Pubitemid 37352465)
9. Creed F, Ratcliffe J, Fernandez L, et al. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med. 2001;134:860-868. (Pubitemid 32405694)
10. Evans BW, Clark WK, Moore DJ, et al. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database Syst Rev. 2007;4:CD003960.
11. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther. 2002;16:1171-1185. (Pubitemid 34680762)
12. Camilleri M, Northcutt AR, Kong S, et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000;355:1035-1040. (Pubitemid 30162805)
13. Watson ME, Lacey L, Kong S, et al. Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2001;96:455-459.
14. Van Outryve M, Mayeur S, Meeus MA, et al. A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome. J Clin Pharm Ther. 1995;20:277-282.
15. Inauen W, Halter F. Clinical efficacy, safety and tolerance of mebeverine slow release (200 mg) versus mebeverine tablets in patients with irritable bowel syndrome. Drug Invest. 1994;8:234-240. (Pubitemid 24319462)
16. Gilbody JS, Fletcher CP, Hughes IW, et al. Comparison of two different formulations of mebeverine hydrochloride in irritable bowel syndrome. Int J Clin Pract. 2000;54:461-464.
17. Mönnikes H, Hecker H, Heymann-Mönnikes I, et al. Predictive factors of treatment success in irritable bowel syndrome in primary care. Z Gastroenterol. 2001;39:714.
18. Cohen BH, Lea RB. Essentials of Statistics for the Social and Behavioral Sciences. New York: John Wiley & Sons; 2003.
19. Schmulson M, Lee OY, Chang L, et al. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol. 1999;94:2929-2935. (Pubitemid 29482760)
20. Simrén M, Abrahamsson H, Svedlund J, et al. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol. 2001;36:545-552. (Pubitemid 32328447)
21. Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology. 2005;128:580-589. (Pubitemid 40585359)
22. Hahn BA, Kirchdoerfer LJ, Fullerton S, et al. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther. 1997;11:553-559. (Pubitemid 27286958)